SOURCE: Yasheng Group

September 07, 2005 09:30 ET

YaSheng Introduces New Medicine to Cure Vascular Diseases

REDWOOD CITY, CA -- (MARKET WIRE) -- September 7, 2005 -- The YaSheng Group (OTC: YHGG) Pharmaceutical Division and Research Center introduced a new patented technology that promotes the formulation and multiplication of new blood vessels in the human body to combat vascular diseases.

The new patent (NO.03100580.0) is designed to treat peculiar functions in muscles, bones and organs of the human body which have inadequate blood flow by sparking multiplied growth of new vessels, increasing blood supply and collateral circulation. The YaSheng Group Pharmaceutical Division reports remarkable results in testing the new medication on the cardiovascular system citing a drastic improvement in the congenital vesicular circulatory. Market Research indicates a high potential for the need of this new medicine in terms of demand and revenues. The company has plans for production and will market the new medicine domestically.

About YaSheng Group:

The YaSheng Group (OTC: YHGG) is a diversified industrial conglomerate incorporated in Redwood City, California, operating in hi-tech agriculture, salt chemistry and biological technology as its core business with advantages in rich land, mineral resources, capital and technology reserves.

Through its 136 subsidiaries, the company operating categories include: chemical engineering, agricultural production, biotech, pharmaceuticals, textile products, printing and dyeing, commercial trading, beverages and inorganic salt manufacturing.

Forward-Looking Statements:

Certain statements contained in this press release are forward-looking statements that involve risks and uncertainties. The statements contained herein that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements deal with the Company's current plans, intentions, beliefs and expectations and statements of future economic performance. Statements containing terms like "believes," "does not believe," "plans," "expects," "intends," "estimates," "anticipates" and other phrases of similar meaning are considered to imply uncertainty and are forward-looking statements.

Contact Information